GuruFocus.com12h agobearish
Anthropic AI Discovery Gene-Editing Stocks FallingAnthropic says Claude identified a novel enzyme system with characteristics reminiscent of CRISPR
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
143last 24h
876last 7d
147● bullish (7d)
98● bearish (7d)
214publishers
Simply Wall St.68d agobearish
Has CRISPR Therapeutics (CRSP) Fallen Far Enough To Look Undervalued?CRISPR Therapeutics stock has delivered a decline of about 61% over the past five years, yet current valuation checks suggest the shares now sit closer to "about right" territory rather than looking clearly cheap or clearly expensive. The roughly 60.9% five year share price decline points to investors reassessing how much they are willing to pay for CRISPR Therapeutics' long term gene editing opportunity. Strong cash of around US$2.4b that has been highlighted in recent coverage can support...
Simply Wall St.83d agobearish
CRISPR Therapeutics (CRSP) Is Up 11.3% After Broad Russell Growth Index Inclusion Has The Bull Case Changed?In late June 2026, CRISPR Therapeutics AG was added to several Russell growth indexes, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, and Small Cap Comp Growth benchmarks. This broad index inclusion increases the company’s visibility to benchmarked funds and could meaningfully influence how investors view its role in growth-oriented portfolios. We’ll now examine how this broad Russell growth index inclusion shapes CRISPR Therapeutics’ investment narrative and...
Zacks99d agobearish
CRISPR Therapeutics AG (CRSP) Ascends While Market Falls: Some Facts to NoteIn the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $53.09, indicating a +2.06% shift from the previous trading day.
Zacks105d agobearish
CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key FactsIn the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $50.27, denoting a +1.68% move from the preceding trading day.
Zacks106d agobearish
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to KnowCRISPR Therapeutics AG (CRSP) concluded the recent trading session at $49.47, signifying a -3.9% move from its prior day's close.
Zacks142d agobearish
CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss EstimatesCRSP posts a wider Q1 loss and revenues miss, pressuring shares, even as Casgevy sales grow and cash reserves strengthen from recent financing.